But even in those trials, many patients didn’t benefit from the immunotherapies. The failed lung-cancer study underscores the challenges in expanding immunotherapy beyond those patients who now benefit—the aim of dozens of companies now developing such agents.
Findings could lead to promising new treatments for people with glioblastoma.
Immunotherapy,免疫療法 also called biologic therapy, is a type of cancer treatment designed to boost the body's natural defenses to fight the cancer. It uses substances either made by the body or in a laboratory to improve or restore immune system function.